Queensland invests in global mRNA vaccine hub


Thursday, 08 December, 2022

Queensland invests in global mRNA vaccine hub

Sanofi, one of the world’s largest vaccine innovators, has partnered with the Queensland Government, The University of Queensland (UQ) and Griffith University to inject $280 million into a next-generation mRNA vaccine research hub based in Brisbane. Sanofi operates 20 research and development sites around the world exploring new medicines and vaccines through translational science, where researchers work to translate early observations in the laboratory into clinical results that directly benefit people.

The Translational Science Hub will link world-class researchers in Queensland with scientists at the Sanofi mRNA Centre of Excellence in France and the US, creating a global vaccines R&D network focused on mRNA technology and translational science. Premier Annastacia Palaszczuk said Queensland will be the only jurisdiction in Australia to have a centre like this, placing the state at the forefront of vaccine development and biomedical research.

“Queensland has some of the best researchers in the world, and the Translational Science Hub will give them the platform to develop life-saving medicines and vaccines,” Palaszczuk said.

mRNA technology is expected to deliver a new generation of vaccines that instruct certain cells to produce proteins that are recognised by the immune system to mount a defence. The initial focus of the Hub will be on improving mRNA technology and developing a first-ever vaccine for chlamydia, a sexually transmissible infection (STI) of increasing public health concern because of its association with infertility, pelvic inflammatory disease and pregnancy complications.

The Hub will utilise laboratories and infrastructure at UQ, Griffith University and the Translational Research Institute (TRI), with the research expected to commence early next year. Deputy Premier and Minister for State Development Steven Miles said the Hub would help drive the development of new vaccines and healthcare solutions across the world, while creating up to 200 jobs for Queenslanders and strengthening the local biomanufacturing supply chain.

“The Hub will bring more expertise, supply-chain capabilities, as well as clinical investigations to Queensland,” Miles said.

“We’re proud one of the world’s largest healthcare companies has chosen Queensland to help reshape 21st-century medicine.”

“For Sanofi, collaboration is absolutely critical when combatting disease,” concluded Karen Hood, Country Lead, Sanofi Australia and New Zealand. “The Translational Science Hub shows we are proud to invest in Australia and work as partners to harness cutting-edge science to forge a new era in medical innovation. By linking our global expertise with the knowledge bank here in Australia, we will help nurture a science ecosystem that is expected to create research and industry jobs in Queensland.”

Image credit: iStock.com/kemalbas

Please follow us and share on Twitter and Facebook. You can also subscribe for FREE to our weekly newsletters and bimonthly magazine.

Related News

Epstein–Barr virus promotes faster nasopharyngeal cancer growth

The Epstein–Barr virus tricks human cells into turning on specific genes that promote...

New MDMA variants could enable safe psychotherapeutic use

The newly developed MDMA variants have been modified in such a way that the positive effects are...

Gene-editing nanoparticles correct mutations in CF models

The nanoparticles successfully edited the disease-causing gene in the lungs of a mouse model of...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd